Cubist’s Experimental Antibiotic Zerbaxa gets nod from FDA

December 20, 2014 12:30 PM

22 0

The US FDA has approved the experimental antibiotic Zerbaxa for the treatment of typical urinary tract infections and intra abdominal infections. The experimental antibiotic Zerbaxa is a product by Cubist Pharmaceuticals Inc.

The Federal regulators on Friday approved a new antibiotic which will fight intra-abdominal and urinary tract infections. The antibiotic is being developed by Lexington’s Cubist Pharmaceuticals Inc., and has a brand name of Zerbaxa. Zerbaxa combines ceftolozane, a new antibiotic, and an existing dru...

Read more

To category page